Correction: Report of Specific Cardiovascular Outcomes of the ADVANTAGE Trial

We recently published a letter by Egilman and Presler (1) that cited a letter from an official at Merck & Co., Inc. (Whitehouse Station, New Jersey) to the U.S. Food and Drug Administration (FDA) …

This 100-word excerpt has been provided in the absence of an abstract.

[Full Text of this Article]
| Table of Contents

This Article

  1. Ann Intern Med June 20, 2006 vol. 144 no. 12 943
  1. » ExcerptFREE
  2. Full Text
  3. Full Text (PDF)

Comments

  1. Submit a comment
  2. No comments published

Share

Current Issue

  1. February 7, 2012, 156 (3)
  1. Alert me to current issues
Most Read Most Read
Most Commented Most Commented On
Annals in the News Annals in the News
Clinical Trials Clinical Trials
Comparative Effectiveness Comparative Effectiveness
Hospital Medicine Hospital Medicine
  • Advertisement
  • Advertisement